Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 10Brain Neoplasms 3Urogenital Diseases 2Neoplasms 2Glioblastoma 2Disease 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Glioma 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × fluciclovine F-18 × Clear all
NCT03081884 2021-01-25

EDRN-FACBC

Emory University

Phase 2 Completed
61 enrolled 6 charts
Genitourinary

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT02830880 2020-01-07

FACBC Prostate Therapy Response

Emory University

Phase 2 Completed
7 enrolled 10 charts
Genitourinary

Urogenital Diseases, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡